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ABSTRACT 
Aims: We evaluated whether pathophysiological events in the brain in sepsis are mediated 
by ET-1/ETB receptor axis. 
Main methods: We prepared raw fecal fluid from soft stool of mice. Mice were randomly 
divided into three groups: pre-PBS + raw fecal fluid group (Sepsis, easy stool method 
(ESM) group); pre-BQ788 + raw fecal fluid group (BQ group); and pre-BQ788 + PBS 
group (PBS group). According to each experimental condition, PBS or BQ788 was 
intravenously injected into mice prior to intraperitoneal administration of fecal fluid or 
PBS. All groups of mice were sacrificed at 8 h after administration, and then brain samples 
were prepared. 
Key findings: In the ESM group, an increase of apoptotic neuroblasts was demonstrated in 
the subgranular zone of the hippocampal dentate gyrus, enhanced expression of c-FOS was 
observed in arginine-vasopression-containing neurons in the hypothalamic paraventricular 
nucleus, and various cytokines involving TNF-α were upregulated in the brain, compared 
with those in the PBS group. In the region corresponding to their findings, the number of 
reactive microglia and vascular leakage were markedly increased. BQ788 inhibited the 
induction of c-FOS expression, neuroblast apoptosis, cytokine upregulation and reactive 
microglia without affecting vascular leakage. 
Significance: We demonstrated that BQ788 could protect the brain from the following 
sepsis-associated pathophysiological output: neural cell death, inflammatory response and 
the Hans Selye’s environmental stress reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Sepsis is a systemic inflammatory response that mainly results from bacterial infection 
(Bone et al. 1997; Levy et al. 2001). To date, severe sepsis and septic shock are still the 
most common cause of death in adult intensive care units, despite advances in critical care 
medicine (Moreno et al. 2008). It is therefore now more important to elucidate the 
mechanism of sepsis than to develop further effective treatment for it. 
It has been reported that endothelin (ET)-1 is associated with severity of 
sepsis/endotoxemia (Pittet et al. 1991; Eakes et al. 1997). Likewise, nonselective ET 
receptor antagonist attenuated organ injury, and decreased mesenteric blood flow in 
endotoxemia/cecal ligation and puncture (CLP), which has been widely accepted as an 
animal model of sepsis (Erdem et al. 2007). In a neonatal sepsis model, blockade of ETA 
attenuated the inflammatory response and prolonged survival time (Goto et al. 2010). On 
the other hand, it is suggested that not ETA but ETB upregulated under polymicrobial septic 
condition plays a key role in alteration of hepatic hemodynamics (Kim et al. 2004; Eum et 
al. 2007). Likewise, nonselective ETA/ETB antagonist but not ETA antagonist markedly 
decreased the mortality rate of LPS-treated rats, and upregulation of both ET-1 and ETB in 
the heart of LPS-treated rats was observed, whereas ETA was markedly downregulated in 
the heart, lung and liver of LPS-treated rats, suggesting a crucial role of ETB in the 
pathogenesis of sepsis (Ishimaru et al. 2001). These previous reports tempt us to consider 
the possibility that ETB rather than ETA might play the pathophysiological role in 
endotoxemia. 
Sepsis-associated encephalopathy (SAE), a global cerebral dysfunction induced by the 
systemic response to inflammation and infection, is associated with increased morbidity 
and mortality (Ziaja. 2013). In patients with sepsis, patients with an acutely altered mental 
status due to sepsis had a higher mortality (49%) than patients with normal mental status 
(26%), indicating that SAE can lead to a 2-fold increase in the risk of death (Sprung et al. 
1990). As a plausible scenario of SAE development, the following events are thought to 
occur sequentially: cerebral endothelial activation starts an inflammatory process by 
releasing inflammatory mediators or by leading inflammatory mediators into the 
parenchyma through the impaired blood-brain barrier (BBB); and inflammatory mediators 
affect cellular metabolism and activity of various types of cells resulting in pathologic 
abnormalities that range from alterations of neurotransmission to apoptosis (Sharshar et al. 
2010). In the sequence of events, activated microglia is hypothesized to play a pivotal role 
in neuroinflammation leading to delirium (van Gool et al. 2010). However, the underlying 
pathophysiology in SAE is still not fully understood. In addition, the correlation between 
SAE and ET/ETR signaling has never been demonstrated.  
In the central nervous system (CNS), ETB is predominantly expressed in astrocytes and 
microglias (Ozawa et al. 1997; Ehninger and Kempermann 2008). Glial cells are strongly 
related to inflammatory response in the CNS via various functions such as 
antigen-presenting capacity, production of proinflammatory cytokines, and maintenance of 
the blood-brain barrier (Yuan et al. 2010). These findings suggest that the ETB-mediated 
signal could participate in inflammatory brain diseases, and that blockade of ETB may 
restore disorder of brain function induced by inflammation. 
Here, we investigated whether BQ788, an ETB-selective antagonist, inhibits 
pathophysiological changes in the brain in response to sepsis, focusing on output of SAE, 
leakage of BBB, activation of glial cells, apoptosis of brain stem/progenitor cells and 
induction of cytokines in the brain. 
 
MATERIALS AND METHODS 
Mice 
Male C57BL/6J mice were purchased from Clea Japan (Tokyo, Japan). We treated 
8~10-week-old mice as subjects, and 10~12-week-old mice as stool donors. Animals were 
housed in the Animal Resource Facility at Chiba University under pathogen-free 
conditions and cared for according to the animal care guidelines of Chiba University. The 
studies were performed according to an animal protocol approved by the Committee of 
Animal Welfare of Chiba University. 
Induction of sepsis 
The intestine including the cecum from donor mice was excised, and soft stool was 
extracted in phosphate-buffered saline (PBS). The extracted stool was centrifuged at 500 g 
for 5 min, and the resulting supernatant was diluted with PBS to obtain turbidity of 0.15 at 
OD600. We have confirmed that intraperitoneal (i.p.) injection of 300 µl of stool fluid can 
induce sepsis in mice, with a pathological profile close to the common sepsis model, CLP 
(Dejager et al. 2011). Colony forming units of 300 µl of stool fluid were 7 x 10
5
/24 h and 
1.7 x 10
7
/24 h under aerobic condition and anaerobic condition, respectively. By an 
analysis of genomic 16S rRNA sequences of each colony randomly picked up, the 
presence of Bacillus, Bacteroides, Escherichia, Eubacterium, Lactococcus, Lactobacillus, 
Proteus and Parabacteroides bacteria was confirmed, indicating that the stool fluid 
contains at least aerobic Gram-negative organisms leading to acute physiological features 
of sepsis in human peritonitis (Parker and Watkins. 2001). Likewise, a comprehensive 
investigation of plasma cytokines/chemokines by western blot (WB) array indicated that 
stool fluid induces a cytokine storm in peripheral blood. Furthermore, all mice died within 
24 h of stool fluid injection, indicating that our ESM induces a severe sepsis. (Naito et al. 
2013; Manuscript in preparation). To evaluate the effect of BQ788 on the brain in sepsis, 
mice were divided into three groups: PBS group, intravenous (i.v.) injection of 500 µl 
BQ788 (10 µg/mouse) 15 min prior to i.p. injection of 300 µl PBS; ESM group, i.v. 
injection of 500 µl PBS 15 min prior to i.p. injection of 300 µl stool fluid; and BQ group, 
i.v. injection of 500 µl BQ788 (10 µg/mouse) 15 min prior to i.p. injection of 300 µl stool 
fluid. Mice were sacrificed after 8 h. We confirmed that an i.v. injection of BQ788 alone 
affects neither plasma levels of cytokines/chemokines nor brain histology under the resting 
state. 
Immunofluorescent study of brain sections 
After fixation followed by dehydration, the brains were frozen in Tissue Tek OCT 
compound (Sakura Finetek, Torrance, CA). Freshly cut brain sections (30 μm) were 
subjected to reaction with rabbit anti-c-Fos antibody (Merck&Co., Inc., New Jersey), 
mouse anti-AVP antibody (Santa Cruz Biotech, Santa Cruz, CA), goat anti-doublecortin 
(DCX) antibody (Santa Cruz Biotech), rabbit anti-cleaved/active caspase 3 antibody (Cell 
Signaling Technology, Framingham, MA), rabbit anti-ionized calcium binding adaptor 
molecule 1 (Iba1) antibody (WAKO, Tokyo, Japan) or mouse Cy3-conjugated anti-glial 
fibrillary acidic protein (GFAP) antibody (Sigma-Aldrich, St. Louis, MO). Sections reacted 
with anti-c-Fos, AVP, DCX, cleaved/active caspase 3 or Iba1 antibody were further stained 
with an appropriate fluorescein-conjugated second antibody. Nuclei were stained with 
4’6-diamino-2-phenylindole (DAPI). In all experiments, coronal sections fitting to the 
same atlas images from each group (PBS, ESM and BQ; 6 mice/each group) were 
subjected to immunofluorescent study and observed under a fluorescence microscope 
(Axio Imager A2, Carl Zeiss, Oberkochen, Germany). In some experiments, fluorescence 
profiles were analyzed by an Image Gauge V4.21 (a densitometry software, FUJIFILM, 
Tokyo, Japan) to quantify the fluorescence intensity of Iba1-LI/Iba1
+
 cell or 
GFAP-LI/GFAP
+
 cell. 
Detection of ET-1-like immunoreactivity in the brain 
According to a previous report (Yoshimi et al. 1991), the fraction containing ET-1 was 
prepared from the brain at 8 h of PBS and ESM groups (3 mice/each group). After 
concentrating by a SEPAK C18 column (Sep-Pak® Waters Co., Milford, MA), the 
resulting samples were lyophilized and dissolved in PBS. Then, the aliquots were subjected 
to an Endothelin-1 ELISA kit (Enzo Life Sciences, Inc., Farmingdale, NY) for detection of 
ET-1-like immunoreactivity (LI). 
Detection of cerebral vascular leakage 
The fluorescein-conjugated dextran (FITC-dextran, Sigma-Aldrich) of 10-kDa average 
molecular weight was used as the permeability tracer. The FITC-dextran solution (250 µl 
of 10 mg /ml in PBS) was intravenously injected into mice from the caudal vein 15 min 
prior to the treatment of each group. At a designated time, mice were intracardially 
perfused with PBS, and the brains were dissected out. After fixation followed by 
dehydration, freshly cut brain sections (30 μm) were observed under a fluorescence 
microscope. The resulting fluorescence profile of section was analyzed by an Image Gauge 
V4.21 to quantify the fluorescence intensity of FITC-dextran in each section. 
Expression of cytokines in the brain 
Mice at 8 h of each group were intracardially perfused with PBS, and the brains were 
dissected out. A 3 mm-thick coronal slice (-0.6 mm to bregma ~ +2.4 mm to bregma, 
covering the specific sites of brain where inflammation-associated pathophysiological 
features were observed) was prepared from each brain. After removing the cortex, the slice 
was homogenized in the tissue lysis buffer (Tokuhara et al. 2010) and centrifuged at 9000 g 
for 15 min at 4˚C. The resulting supernatant was used as a protein sample. The mixture 
(250 + 250 µg protein) of two samples from each group was subjected to Proteome Profiler 
Mouse Cytokine Array Kit (ARY 006, R&D systems, Inc., Minneapolis, MN). The array 
was performed twice according to the manufacturer’s instructions. We confirmed the 
reproducibility of changes in expression of cytokines under each condition (PBS, ESM and 
BQ). Then, each cytokine signal was normalized to the positive internal control 
included in the array membrane by using an Image Gauge V4.21. 
Statistical analysis 
Data are expressed as mean ± S.E.M. Statistical analysis was conducted using Graphpad 
Prism Version 6 (GraphPad Software Inc., San Diego, CA). Statistical significance was 
determined by Student’s t test or analysis of variance (ANOVA) followed by Tukey test, 
and p values < 0.05 were considered to be significant. 
 
 
RESULTS  
Elucidation of initial encephalopathic events induced by ESM 
To elucidate whether ESM induces histopathological changes in the brain, we first 
investigated profiles of Iba1
+
 microglia or GFAP
+
 astrocyte in the brain. As shown in Fig. 
1A, an immunoreactivity of Iba1 in the brain from the ESM group specificically increased 
in the dentate gyrus (DG) of the hippocampus, the thalamus and the hypothalamus 
compared with that from the PBS group. An increase in immunoreactivity of GFAP in the 
ESM group was observed in the corresponding area where Iba1-LI increased. Under these 
situations, ET-LI in the brain was significantly elevated by ESM (Fig. 1B). As the 
breakdown of BBB is one of typical events in SAE, a time-dependent vascular leakage was 
monitored by FITC-dextran. As shown in Fig. 1C, ESM induced the breakdown of BBB in 
the hippocampus within 1 h. Then, to address to whether ET-1/ ETB system is involved in 
the inflammation-associated changes in the brain, effect of BQ788 on ESM-induced 
pathophysiological changes in the specific sites was elucidated. A single i.v. injection of 
BQ788 was employed in the present study because the delivery of BQ788 to the brain 
parenchyma through the impaired BBB was expected (Fig. 1C). Likewise, it has been 
demonstrated that a single i.v. injection of BQ788 could exert its inhibitory effect at least 
for 5 h (Piechota-Polañczyk and Gorąca. 2012). 
ESM-induced pathophysiological changes in the DG 
As shown in Fig. 2A, ESM markedly induced both Iba1- and GFAP-LI in the hilus of the 
hippocampal DG compared with the case of the PBS group. Administration of BQ788 
suppressed the ESM-induced Iba1- and GFAP-LI. Quantitative analyses showed that the 
number and the fluorescent intensity/cell of Iba1
+
 cells and GFAP
+
 cells were significantly 
increased by ESM. These parameters were significantly BQ788 treatment-sensitive (Fig. 
2B & C). In such situations, active caspase 3
+
DCX
+
 cells were typically observed in the 
subgranular zone (SGZ) of the hippocampal DG in the ESM group but not the PBS group, 
which was inhibited by BQ788 treatment (Fig. 2D). Changes in the number of active 
caspase 3
+
DCX
+
 cells in the three groups are shown in Fig. 2E. On the other hand, the 
intensity of FITC-dextran in the hippocampus in the ESM group was markedly increased 
compared with that in the PBS group, which was not suppressed by BQ788 treatment (Fig. 
2F). 
ESM-activated neuroendocrine cells in the paraventricular nucleus of the hypothalamus 
Typical profiles of c-FOS-LI observed in the paraventricular nucleus (PVN) of the 
hypothalamus in three groups were shown in Fig. 3A. The marked induction of c-FOS by 
ESM was significantly inhibited by BQ788 treatment (Fig. 3B). Most of c-FOS-LI induced 
by ESM were overlapped with AVP-LI in the PVN of the hypothalamus (Fig. 3C). In the 
corresponding areas, the number of Iba1
+
 and GFAP
+
 cells was increased by ESM, which 
was sensitive to BQ788 treatment (Fig. 3D). BQ788 did not affect ESM-induced 
impairment of the BBB, the same as the case for the hippocampus (Fig. 3E). 
ESM-induced expression of cytokines in the brain 
To elucidate the relationships between the inflammation-associated pathophysiological 
output and inflammatory mediators, WB array analysis of cytokines in the specific sites of 
the brain was performed. Typical changes in expression of cytokines in three groups were 
shown in Fig. 4A, ESM obviously upregulated the expression of various cytokines, which 
was mostly sensitive to BQ788 treatment. A densitometric analysis of two experiments 
revealed that expression of 13 proteins exhibiting over 2-fold induction by ESM was 
reduced more than 30% by BQ788 treatment. Those 13 proteins’ names were indicated 
with the correct location in the membrane map (Fig. 4A), and each signal expressed as an 
average intensity of two experiments was shown in Fig. 4B. 
 
DISCUSSION 
Sepsis is associated with marked brain inflammation, and the resulting brain dysfunction 
including neuronal apoptosis and neuroendocrine system damage affects sepsis-induced 
organ dysfunction in a positive feedback manner (Sharshar et al. 2005). However, 
sepsis-associated apoptosis of brainstem/progenitor cells has not been clarified. Likewise, 
the correlation between the neuroendocrine cells-mediated hypothalamic-pituitary-adrenal 
(HPA) axis, a part of Hans Selye’s environmental stress reaction, and sepsis remains to be 
elucidated. Furthermore, the involvement of the ETB-mediated signal in these 
sepsis-associated events has never been investigated. In the present study, we clearly 
showed that sepsis-associated encephalopathic events such as an increased number of 
reactive microglia and induction of various proinflammatory mediators could be regulated 
by ET-1/ETB axis in our ESM model mice. In particular, among the ESM-induced 
cytokines sensitive to BQ788 (Fig. 4B), TNF-α in concert with activated microglia plays a 
crucial role in the development of brain dysfunction after systemic infection (van Gool et 
al. 2010; Clark et al. 2010). In addition, we also found that ESM increased the number of 
active caspase 3
+
DCX
+
 cells in the SGZ and c-FOS
+
AVP
+
 cells in the hypothalamic PVN 
in the areas where an increase in both reactive microglias and astrocytes were observed. 
Furthermore, those events were significantly suppressed by BQ788. 
The SGZ as well as subventricular zone (SVZ) is recognized as the major source of new 
neurons in the adult brain (Burtrum and Silverstein 1994). A sepsis-induced increase of 
neurogenesis in the SVZ but not SGZ has been shown (Bakirci et al. 2011). This finding 
suggests that sepsis may not affect either apoptosis or neurogenesis in the SGZ, 
considering the context of apoptosis and neurogenesis in the adult brain (Chambers et al. 
2004). In our sepsis model, however, typical inflammation-associated pathophysiological 
features were observed in the hippocampal DG. Then, active caspase 3
+
DCX
+
 cells in the 
SGZ were evaluated. Caspase 3, which is often activated in the apoptotic pathway, is a 
reliable marker for apoptotic cells (Maurya et al. 2013). DCX is a microtubule-associated 
protein expressed by neuronal precursor cells and immature neurons in embryonic and 
adult cortical structures, indicating that DCX is a marker for neuroblasts (Gleeson et al. 
1998). Hence, the changes in number of active caspase 3
+
DCX
+
 cells in three groups (PBS, 
ESM and BQ) suggest that the ETB signal mediates sepsis-induced neural progenitor 
apoptosis in the SGZ. Apoptotic mediators for neural stem or progenitor cells in the 
hippocampus under pathophysiological conditions remain to be elucidated. It has reported 
that LPS-induced apoptosis in hippocampus-derived neural stem cells could be protected 
by imipramine, a tricyclic antidepressant drug, through upregulation of brain-derived 
neurotrophic factor (BDNF) (Peng et al. 2008). Likewise, the administration of imipramine 
to maternal deprivation stress model rats significantly suppressed the levels of TNF-α 
having a counter effect on BDNF in the serum and cerebrospinal fluid of rats (Réus et al. 
2013). In line with these findings, TNF-α may be a prominent candidate for the neural 
progenitor apoptosis in the SGZ. 
The HPA axis is activated during bacterial and viral infections (Webster and Sternberg 
2004). Expression of c-FOS is often used as a marker of neuronal cell activation (Kovács 
1998). Our finding that ESM-induced c-FOS expression was mostly overlapped with AVP
+
 
cells in the hypothalamic PVN strongly suggest the ESM-induced activation of 
neuroendocrine cells (Harbuz. 2002). The relationships between cytokines and HPA axis 
activation are well defined. In particular, IL-1α/β leads to a potent and prolong activation 
of HPA axis, and TNF-α also plays an activator for HPA axis (Dunn. 2000). The 
ESM-induced IL-1α and TNF-α expression sensitive to BQ788 suggest that the ET-1/ETB 
system-upregulated IL-1α and TNF-α might affect HPA axis (Figs. 3 & 4B). 
Monitoring BBB function by FITC-dextran showed that the cerebral vascular leakage was 
induced at least from 1h to 8 h after ESM application (Figs. 1C, 2F & 3E). The 
ESM-induced BBB breakdown was observed in the corresponding areas where the 
inflammation-associated pathophysiological output. However, BQ788 can block neural 
progenitor cell death and HPA axis activation associated with inflammatory changes in the 
brain parenchyma in response to sepsis without affecting sepsis-induced impairment of the 
BBB. Previous report has clearly demonstrated that not ETA but ETB on endothelial cells 
plays a crucial role in the impairment of BBB function in concert with endogenous ET-1 
(Reijerkerk ei al. 2012). The BQ788-insensitive ESM-induced BBB breakdown in the 
present study may be explained by the finding that a high concentration of BQ788 is 
needed to express its inhibitory effect on BBB damage compared with the case of ETB 
shRNA (Reijerkerk ei al. 2012) or by the possibility that ESM-induced insult in BBB may 
be far beyond the effect of BQ788. In any case, our finding that sepsis-associated various 
proinflammatory mediators in the brain was clearly sensitive to BQ788 regardless of the 
state of BBB suggest that ET-1/ETB-mediated CNS inflammation might be independent of 
systemic cytokines. This notion is supported by a previous report that TLR4 function in 
CNS-resident cells, independent of systemic cytokine effects, is required for sustained 
CNS-specific inflammation during endotoxemia (Chakravarty and Herkenham. 2005). 
Under our current experimental condition of ESM, treatment of mice in sepsis with BQ788 
could not increase the survival rate of mice. As a next step, to evaluate the possibility that 
BQ788 is used for treatment of sepsis, an electroencephalographic study and a survival rate 
analysis are needed under a moderate condition controlling the insult intensity of ESM. 
 CONCLUSION 
We newly demonstrated that ETB-mediated signaling participates in pathophysiological 
features of SAE. 
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FIGURE LEGENDS  
Figure 1 ESM-induced pathophysiological output in the brain. A) Iba1-LI and GFAP-LI in 
the PBS and ESM groups. Coronal sections fitting to the same atlas images from each 
group (8 h after treatment) were immunostained with anti-Iba1 (green) and anti-GFAP 
(red). All sections were stained with DAPI (blue). Arrow heads indicate matching areas 
between two groups. Similar results were obtained in independent experiments (n=6). B) 
ESM induces ET-1 expression in the brain. The brain from each group (8 h after treatment) 
was subjected to ET-1 extraction and concentration followed by EIA. Data are shown as 
mean with S.E.M (n=3). *P < 0.05 (Student’s t test). C) ESM induces cerebral vascular 
leakage. Hippocampi of coronal sections fitting to the same atlas images from the 
FITC-dextran-loaded brains of each group (indicated time after treatment) were observed 
under a fluorescence microscope. The fluorescence intensity of FITC was analyzed by a 
densitometer. Data are shown as mean with S.E.M (n=4). *P < 0.05 (ANOVA followed by 
Tukey test). LV, lateral ventricle; D3V, dorsal third ventricle; 3V, third ventricle. 
 
Figure 2 ESM-induced pathophysiological output in the hippocampal DG. A) Typical 
profile of Iba1
+
 and GFAP
+
 cells in the DG in three groups (PBS, ESM and BQ788). 
Coronal sections fitting to the same atlas images from each group (8 h after treatment) 
were immunostained with anti-Iba1 (green) and anti-GFAP (red). All sections were stained 
with DAPI (blue). B) The number of cells expressing Iba1 or GFAP in the hilus of the DG 
in three group. Data are shown as mean with S.E.M (n=6). *P < 0.05 (ANOVA followed 
by Tukey test). C) The intensity of Iba1-LI/Iba1
+
 cell and GFAP-LI /GFAP
+
 cell in the 
hilus of the DG in three group as an index of reactive microglia and astrocyte by a 
densitmetric analysis. Data are shown as mean with S.E.M (n=6). *P < 0.05 (ANOVA 
followed by Tukey test). D) Typical profile of active caspase 3
+
/DCX
+
 cells in the DG in 
three groups (PBS, ESM and BQ788). Coronal sections fitting to the same atlas images 
from each group (8 h after treatment) were immunostained with anti-active caspase 3 
(green) and anti-DCX (red). All sections were stained with DAPI (blue). E) The number of 
cells coexpressing active caspase 3 and DCX in the hilus of the DG in three group. Data 
are shown as mean with S.E.M (n=6). *P < 0.05 (ANOVA followed by Tukey test). F) 
ESM induces cerebral vascular leakage in the hippocampus. Hippocampi of coronal 
sections fitting to the same atlas images from the FITC-dextran-loaded brains of each 
group (8 h after treatment) were observed under a fluorescence microscope. The 
fluorescence intensity of FITC was analyzed by a densitometer. Data are shown as mean 
with S.E.M (n=4). *P < 0.05 (ANOVA followed by Tukey test). 
 
Figure 3 ESM activates neuroendocrine cells in the hypothalamic PVN. A) Typical profile 
of c-FOS
+
 cells in the hypothalamic PVN in three groups (PBS, ESM and BQ788). 
Coronal sections fitting to the same atlas images from each group (8 h after treatment) 
were immunostained with anti-c-FOS (red). All sections were stained with DAPI (blue). B) 
The number of cells expressing c-FOS in the hypothalamic PVN in three group. Data are 
shown as mean with S.E.M (n=6). *P < 0.05 (ANOVA followed by Tukey test). C) 
ESM-induced c-FOS-LI is mostly localized in AVP
+
 cells. Coronal sections from ESM 
group (8 h after treatment) were immunostained with c-FOS (red) and anti-AVP (green). 
All sections were stained with DAPI (blue). D) The number of cells expressing Iba1 or 
GFAP in the hypoyhalamic PVN in three group. Data are shown as mean with S.E.M (n=6). 
*P < 0.05 (ANOVA followed by Tukey test). E) ESM induces cerebral vascular leakage in 
the hypothalamus. Hypothalami of coronal sections fitting to the same atlas images from 
the FITC-dextran-loaded brains of each group (8 h after treatment) were observed under a 
fluorescence microscope. The fluorescence intensity of FITC was analyzed by a 
densitometer. Data are shown as mean with S.E.M (n=4). *P < 0.05 (ANOVA followed by 
Tukey test). 
 
Figure 4 ESM-induced proinflammatory mediators in the specific sites of brain. A) 
Typical profiles of protein array for 40 cytokines in three groups (PBS, ESM and BQ788). 
13 molecules (> 200% induction, ESM vs. PBS; > 30% reduction, BQ788 vs. ESM) 
showing reproducible profile in two experiments were selected by a densitometric analysis 
and indicated with the correct location in the membrane map. B) Densitometric analysis of 
the 13 molecules in three groups. Signal intensity is expressed as arbitrary units 
relative to the positive internal control. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life Sciences  vol.118  No.2 
平成 26年 3月 20日公表済 
